Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.55 Insider Own29.15% Shs Outstand24.55M Perf Week1.08%
Market Cap46.15M Forward P/E- EPS next Y-2.86 Insider Trans-3.35% Shs Float17.40M Perf Month7.43%
Income-68.83M PEG- EPS next Q-0.69 Inst Own43.02% Short Float5.54% Perf Quarter-9.18%
Sales23.84M P/S1.94 EPS this Y-4.10% Inst Trans13.61% Short Ratio2.90 Perf Half Y-60.17%
Book/sh3.68 P/B0.51 EPS next Y-12.44% ROA-48.86% Short Interest0.96M Perf Year-75.80%
Cash/sh3.60 P/C0.52 EPS next 5Y- ROE-58.22% 52W Range1.55 - 8.49 Perf YTD-6.93%
Dividend Est.- P/FCF- EPS past 5Y11.87% ROI-75.47% 52W High-77.86% Beta0.65
Dividend TTM- Quick Ratio4.86 Sales past 5Y225.26% Gross Margin87.70% 52W Low21.29% ATR (14)0.12
Dividend Ex-Date- Current Ratio5.16 EPS Y/Y TTM3.11% Oper. Margin-313.00% RSI (14)48.58 Volatility4.12% 7.38%
Employees89 Debt/Eq0.08 Sales Y/Y TTM26.97% Profit Margin-288.72% Recom1.40 Target Price11.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-19.60% Payout- Rel Volume0.27 Prev Close1.84
Sales Surprise-17.26% EPS Surprise-8.97% Sales Q/Q-8.76% EarningsMay 08 BMO Avg Volume332.36K Price1.88
SMA20-1.53% SMA50-5.51% SMA200-43.61% Trades Volume91,127 Change2.17%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Downgrade H.C. Wainwright Buy → Neutral
Jan-11-22Initiated Jefferies Buy $45
Oct-01-21Initiated Cowen Outperform
Sep-14-21Initiated Ladenburg Thalmann Buy $51
Sep-08-21Initiated Piper Sandler Overweight $45
May-23-24 05:30PM
May-09-24 01:52PM
May-08-24 12:53PM
May-01-24 08:01AM
08:00AM Loading…
Apr-09-24 08:00AM
Apr-03-24 09:40AM
Mar-18-24 09:40AM
Mar-17-24 08:00AM
Mar-15-24 10:43AM
Mar-13-24 09:05AM
Mar-06-24 08:00AM
Mar-05-24 04:30PM
Mar-01-24 04:08PM
04:05PM Loading…
Feb-26-24 04:05PM
Jan-26-24 04:05PM
Jan-19-24 04:05PM
Dec-15-23 09:14AM
Dec-14-23 04:05PM
Nov-08-23 08:46AM
Nov-06-23 04:05PM
Nov-01-23 04:05PM
Oct-19-23 04:05PM
Oct-12-23 04:05PM
Oct-05-23 04:05PM
Oct-03-23 04:05PM
Oct-02-23 08:00AM
Sep-20-23 04:30PM
08:00AM Loading…
Sep-05-23 08:00AM
Aug-09-23 08:00AM
Aug-02-23 08:00AM
May-25-23 05:30PM
May-23-23 08:00AM
May-10-23 08:00AM
May-03-23 08:00AM
Apr-26-23 04:05PM
Apr-14-23 01:00PM
Apr-06-23 04:30PM
Mar-28-23 08:00AM
Mar-27-23 08:00AM
Mar-26-23 02:00PM
Mar-15-23 08:00AM
Mar-03-23 08:00AM
Feb-22-23 08:00AM
Nov-17-22 08:00AM
Nov-09-22 08:00AM
Nov-08-22 04:00PM
Nov-03-22 08:00AM
Oct-27-22 08:00AM
Oct-12-22 08:01AM
Sep-22-22 04:01PM
Sep-01-22 08:00AM
Aug-10-22 08:00AM
Aug-04-22 06:21AM
Jul-28-22 08:30AM
Jun-23-22 08:00AM
Jun-01-22 08:00AM
May-31-22 08:00AM
May-26-22 05:10PM
May-18-22 07:00AM
May-12-22 08:32AM
May-09-22 08:00AM
May-04-22 08:00AM
Apr-28-22 05:07PM
Apr-18-22 08:00AM
Apr-08-22 01:09PM
Apr-01-22 05:13AM
Mar-31-22 02:45PM
Mar-17-22 07:00AM
Mar-01-22 07:00AM
Feb-25-22 04:41AM
Feb-23-22 07:00AM
Jan-04-22 04:30PM
Dec-28-21 09:38AM
Dec-23-21 12:38PM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-27-21 06:01AM
Nov-23-21 04:22PM
Nov-15-21 08:00AM
Nov-13-21 01:35PM
Nov-10-21 07:00AM
Nov-09-21 08:00AM
Nov-01-21 04:05PM
Oct-25-21 08:00AM
Oct-22-21 08:00AM
Oct-19-21 05:22PM
Oct-06-21 08:00AM
Sep-20-21 08:30AM
Sep-13-21 08:00AM
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Desai NeilEXECUTIVE CHAIRMANMay 01 '24Sale1.9340,00077,1841,331,543May 01 08:50 PM
Desai NeilEXECUTIVE CHAIRMANApr 02 '24Sale2.2322,22849,5131,371,543Apr 03 04:49 PM
Desai NeilEXECUTIVE CHAIRMANApr 01 '24Sale2.3117,77241,1011,393,771Apr 03 04:49 PM
Desai NeilEXECUTIVE CHAIRMANMar 04 '24Sale2.1014,96431,4151,411,543Mar 04 07:22 PM
Desai NeilEXECUTIVE CHAIRMANMar 01 '24Sale1.9727,03653,2261,426,507Mar 04 07:22 PM
Desai NeilExecutive ChairmanFeb 01 '24Sale1.7442,00073,2691,453,543Feb 02 05:04 PM
Desai NeilExecutive ChairmanJan 02 '24Sale2.0642,00086,5491,495,543Jan 02 07:48 PM
Desai NeilExecutive ChairmanDec 06 '23Sale4.827,03733,9141,537,543Dec 07 04:04 PM
Desai NeilExecutive ChairmanDec 05 '23Sale5.0215,74078,9411,544,580Dec 05 06:40 PM
Desai NeilExecutive ChairmanDec 04 '23Sale5.1510,87655,9861,560,320Dec 05 06:40 PM
Desai NeilExecutive ChairmanDec 01 '23Sale5.148,34742,8811,571,196Dec 05 06:40 PM
Desai NeilExecutive ChairmanNov 02 '23Sale4.4631,662141,1051,579,543Nov 02 06:45 PM
Desai NeilExecutive ChairmanNov 01 '23Sale4.3210,33844,6451,611,205Nov 02 06:45 PM
Desai NeilExecutive ChairmanOct 03 '23Sale4.1016,43167,3031,621,543Oct 03 06:51 PM
Desai NeilExecutive ChairmanOct 02 '23Sale4.3725,569111,6981,637,974Oct 03 06:51 PM
Desai NeilExecutive ChairmanSep 06 '23Sale5.297,11137,6371,663,543Sep 06 07:05 PM
Desai NeilExecutive ChairmanSep 05 '23Sale5.6321,000118,3161,670,654Sep 06 07:05 PM
Desai NeilExecutive ChairmanSep 01 '23Sale5.9713,88982,8731,691,654Sep 06 07:05 PM
Desai NeilExecutive ChairmanAug 02 '23Sale5.2019,290100,2501,705,543Aug 03 04:22 PM
Desai NeilExecutive ChairmanAug 01 '23Sale5.2222,710118,5231,724,833Aug 03 04:22 PM
Desai NeilExecutive ChairmanJul 06 '23Sale6.2715,82999,2731,747,543Jul 06 07:36 PM
Desai NeilExecutive ChairmanJul 05 '23Sale6.5516,171105,8731,763,372Jul 06 07:36 PM
Desai NeilExecutive ChairmanJul 03 '23Sale6.6410,00066,4461,779,543Jul 06 07:36 PM
Desai NeilExecutive ChairmanJun 06 '23Sale8.197,26059,4531,789,543Jun 06 08:11 PM
Desai NeilExecutive ChairmanJun 05 '23Sale8.1117,315140,4181,796,803Jun 05 07:01 PM
Desai NeilExecutive ChairmanJun 02 '23Sale7.9912,44399,4211,814,118Jun 05 07:01 PM
Desai NeilExecutive ChairmanJun 01 '23Sale7.924,98239,4681,826,561Jun 05 07:01 PM